Who owns HERON THERAPEUTICS, INC. /DE/ (HPTX)? Elite investor 13F holders
3 tracked elite investors reported holding HERON THERAPEUTICS, INC. /DE/ as of 2026-06-30, including Rubric Capital, D.E. Shaw, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rubric Capital | HERON THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12823986.00 USD | 30046828.000000 | Shares | hold | Original filing |
| D.E. Shaw | HERON THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 51402.00 USD | 120435.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | HERON THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 643145.00 USD | 1506900.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.